Publications of the Plückthun Group
ZORA Publication List
Download Options
Publications
-
2025
-
Activated blood-derived human primary T cells support replication of HAdV C5 and virus transmission to polarized human primary epithelial cells. Journal of Virology:Epub ahead of print.
-
Custom affinity probes reveal DNA-damage-induced, ssDNA-independent chromatin SUMOylation in budding yeast. Cell Reports, 44(3):115353.
-
DARPin-induced reactivation of p53 in HPV-positive cells. Nature Structural & Molecular Biology:Epub ahead of print.
-
-
2024
-
DARPins as a novel tool to detect and degrade p73. Cell Death and Disease, 15(12):909.
-
Preparation of Polarity-Marked Microtubules Using a Plus-End Capping DARPin. Bio-protocol, 14(22):e5109.
-
Protein degradation kinetics measured by microinjection and live-cell fluorescence microscopy. Scientific Reports, 14(1):27153.
-
Beyond KRAS(G12C): Biochemical and Computational Characterization of Sotorasib and Adagrasib Binding Specificity and the Critical Role of H95 and Y96. ACS Chemical Biology, 19(10):2152-2164.
-
Experimental variables determine the outcome of RAS-RAS interactions. Journal of Biological Chemistry, 300(11):107859.
-
DARPin-fused T cell engager for adenovirus-mediated cancer therapy. Molecular therapy. Oncology, 32(3):200821.
-
Broadening the Utility of Farnesyltransferase-Catalyzed Protein Labeling Using Norbornene-Tetrazine Click Chemistry. Bioconjugate Chemistry, 35(7):922-933.
-
Modular binder technology by NGS-aided, high-resolution selection in yeast of designed armadillo modules. Proceedings of the National Academy of Sciences of the United States of America, 121(27):e2318198121.
-
Preclinical evaluation of EpCAM-binding designed ankyrin repeat proteins (DARPins) as targeting moieties for bimodal near-infrared fluorescence and photoacoustic imaging of cancer. European Journal of Nuclear Medicine and Molecular Imaging, 51(8):2179-2192.
-
A designed ankyrin-repeat protein that targets Parkinson's disease-associated LRRK2. Journal of Biological Chemistry, 300(7):107469.
-
mRNA Display Pipeline for Protein Biosensor Construction. ACS Sensors, 9(6):2846-2857.
-
Designed Ankyrin Repeat Proteins as Actin Labels of Distinct Cytoskeletal Structures in Living Cells. ACS Nano, 18(12):8919-8933.
-
Gutless helper-dependent and first generation HAdV5 vectors have similar mechanical properties and common transduction mechanisms. Human Gene Therapy, 35(5-6):163-176.
-
Identification of a Novel Subtype-Selective α$_{1B}$-Adrenoceptor Antagonist. ACS Chemical Neuroscience, 15(3):671-684.
-
-
2023
-
A DARPin promotes faster onset of botulinum neurotoxin A1 action. Nature Communications, 14(1):8317.
-
Unexpected dynamics in femtomolar complexes of binding proteins with peptides. Nature Communications, 14(1):7823.
-
Side‐chain dynamics of the α$_{1B}$ ‐adrenergic receptor determined by NMR via methyl relaxation. Protein Science, 32(11):e4801.
-
DARPins detect the formation of hetero-tetramers of p63 and p73 in epithelial tissues and in squamous cell carcinoma. Cell Death and Disease, 14(10):674.
-
FAP-retargeted Ad5 enables in vivo gene delivery to stromal cells in the tumor microenvironment. Molecular Therapy, 31(10):2914-2928.
-
Assessing immunogenicity barriers of the HIV-1 envelope trimer. npj vaccines, 8(1):148.
-
Trapping the HIV-1 V3 loop in a helical conformation enables broad neutralization. Nature Structural & Molecular Biology, 30(9):1323-1336.
-
Nuclear myosin VI maintains replication fork stability. Nature Communications, 14(1):3787.
-
Targeted adenovirus-mediated transduction of human T cells in vitro and in vivo. Molecular Therapy - Methods & Clinical Development, 29:120-132.
-
Designed ankyrin repeat proteins for detecting prostate-specific antigen expression in vivo. RSC Chemical Biology, 4(7):494-505.
-
DARPins bind their cytosolic targets after having been translocated through the protective antigen pore of anthrax toxin. Scientific Reports, 13(1):8048.
-
CRISPR-clear imaging of melanin-rich B16-derived solid tumors. Communications Biology, 6(1):370.
-
A Vaccinia-based system for directed evolution of GPCRs in mammalian cells. Nature Communications, 14(1):1770.
-
Targeting Oncolytic Adenoviruses to Cancer Cells Using a Designed Ankyrin Repeat Protein Lipocalin-2 Fusion Protein. Human Gene Therapy, 34(5-6):203-216.
-
Improved Repeat Protein Stability by Combined Consensus and Computational Protein Design. Biochemistry, 62(2):318-329.
-